These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 17956675)

  • 1. [DNA sequencing of miR-17-92 cluster at chromosome 13q31-q32 in mantel cell lymphoma cell lines].
    Xu W; Li JY; Shen QD; Li L; Yu H
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Oct; 15(5):986-8. PubMed ID: 17956675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma.
    Ota A; Tagawa H; Karnan S; Tsuzuki S; Karpas A; Kira S; Yoshida Y; Seto M
    Cancer Res; 2004 May; 64(9):3087-95. PubMed ID: 15126345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The miRNA-17∼92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K/AKT pathway activation.
    Rao E; Jiang C; Ji M; Huang X; Iqbal J; Lenz G; Wright G; Staudt LM; Zhao Y; McKeithan TW; Chan WC; Fu K
    Leukemia; 2012 May; 26(5):1064-72. PubMed ID: 22116552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA expression, chromosomal alterations, and immunoglobulin variable heavy chain hypermutations in Mantle cell lymphomas.
    Navarro A; Beà S; Fernández V; Prieto M; Salaverria I; Jares P; Hartmann E; Mozos A; López-Guillermo A; Villamor N; Colomer D; Puig X; Ott G; Solé F; Serrano S; Rosenwald A; Campo E; Hernández L
    Cancer Res; 2009 Sep; 69(17):7071-8. PubMed ID: 19690137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic action of the microRNA-17 polycistron and Myc in aggressive cancer development.
    Tagawa H; Karube K; Tsuzuki S; Ohshima K; Seto M
    Cancer Sci; 2007 Sep; 98(9):1482-90. PubMed ID: 17608773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-17-92 cluster-BTG2 axis regulates B-cell receptor signaling in mantle cell lymphoma.
    Kawaji-Kanayama Y; Tsukamoto T; Nakano M; Tokuda Y; Nagata H; Mizuhara K; Katsuragawa-Taminishi Y; Isa R; Fujino T; Matsumura-Kimoto Y; Mizutani S; Shimura Y; Taniwaki M; Tashiro K; Kuroda J
    Cancer Sci; 2024 Feb; 115(2):452-464. PubMed ID: 38050664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different breakage-prone regions on chromosome 1 detected in t(11;14)-positive mantle cell lymphoma cell lines and multiple myeloma cell lines are associated with different tumor progression-related mechanisms.
    Rudolph C; Liehr T; Steinemann D; Emura M; Daibata M; Matsuo Y; Emi N; Abe M; Lai R; Mrasek K; Claussen U; Schlegelberger B
    Cytogenet Genome Res; 2006; 112(3-4):213-21. PubMed ID: 16484775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of t(12;14)(p13;q32) in a patient with IGH-CCND1 negative mantle cell lymphoma resembling ultra-high risk chronic lymphocytic leukemia.
    Miao Y; Wang R; Fan L; Qiu H; Wu Y; Chen Y; Xu W; Li J
    Int J Clin Exp Pathol; 2015; 8(6):7494-8. PubMed ID: 26261659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GPC5 is a possible target for the 13q31-q32 amplification detected in lymphoma cell lines.
    Yu W; Inoue J; Imoto I; Matsuo Y; Karpas A; Inazawa J
    J Hum Genet; 2003; 48(6):331-335. PubMed ID: 12721791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-17-92 significantly enhances radioresistance in human mantle cell lymphoma cells.
    Jiang P; Rao EY; Meng N; Zhao Y; Wang JJ
    Radiat Oncol; 2010 Nov; 5():100. PubMed ID: 21040528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylation of miR-155-3p in mantle cell lymphoma and other non-Hodgkin's lymphomas.
    Yim RL; Wong KY; Kwong YL; Loong F; Leung CY; Chu R; Lam WW; Hui PK; Lai R; Chim CS
    Oncotarget; 2014 Oct; 5(20):9770-82. PubMed ID: 25211095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Templated nucleotide addition and immunoglobulin JH-gene utilization in t(11;14) junctions: implications for the mechanism of translocation and the origin of mantle cell lymphoma.
    Welzel N; Le T; Marculescu R; Mitterbauer G; Chott A; Pott C; Kneba M; Du MQ; Kusec R; Drach J; Raderer M; Mannhalter C; Lechner K; Nadel B; Jaeger U
    Cancer Res; 2001 Feb; 61(4):1629-36. PubMed ID: 11245476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Four human t(11;14)(q13;q32)-containing cell lines having classic and variant features of Mantle Cell Lymphoma.
    Tucker CA; Bebb G; Klasa RJ; Chhanabhai M; Lestou V; Horsman DE; Gascoyne RD; Wiestner A; Masin D; Bally M; Williams ME
    Leuk Res; 2006 Apr; 30(4):449-57. PubMed ID: 16183118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allelic genotyping reveals a hierarchy of genomic alterations in mantle cell lymphoma associated to cell proliferation.
    Hutter G; Scheubner M; Ott G; Zimmermann Y; Hübler K; Roth S; Stilgenbauer S; Kalla J; Stöcklein H; Hiddemann W; Dreyling M
    Ann Hematol; 2009 Sep; 88(9):821-8. PubMed ID: 19137297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA signature obtained from the comparison of aggressive with indolent non-Hodgkin lymphomas: potential prognostic value in mantle-cell lymphoma.
    Goswami RS; Atenafu EG; Xuan Y; Waldron L; Reis PP; Sun T; Datti A; Xu W; Kuruvilla J; Good DJ; Lai R; Church AJ; Lam WS; Baetz T; Lebrun DP; Sehn LH; Farinha P; Jurisica I; Bailey DJ; Gascoyne RD; Crump M; Kamel-Reid S
    J Clin Oncol; 2013 Aug; 31(23):2903-11. PubMed ID: 23835716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-17-92 cluster microRNAs confers tumorigenicity in multiple myeloma.
    Chen L; Li C; Zhang R; Gao X; Qu X; Zhao M; Qiao C; Xu J; Li J
    Cancer Lett; 2011 Oct; 309(1):62-70. PubMed ID: 21664042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Truncation in CCND1 mRNA alters miR-16-1 regulation in mantle cell lymphoma.
    Chen RW; Bemis LT; Amato CM; Myint H; Tran H; Birks DK; Eckhardt SG; Robinson WA
    Blood; 2008 Aug; 112(3):822-9. PubMed ID: 18483394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple recurrent chromosomal breakpoints in mantle cell lymphoma revealed by a combination of molecular cytogenetic techniques.
    Salaverria I; Espinet B; Carrió A; Costa D; Astier L; Slotta-Huspenina J; Quintanilla-Martinez L; Fend F; Solé F; Colomer D; Serrano S; Miró R; Beà S; Campo E
    Genes Chromosomes Cancer; 2008 Dec; 47(12):1086-97. PubMed ID: 18709664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive whole genome array CGH profiling of mantle cell lymphoma model genomes.
    de Leeuw RJ; Davies JJ; Rosenwald A; Bebb G; Gascoyne RD; Dyer MJ; Staudt LM; Martinez-Climent JA; Lam WL
    Hum Mol Genet; 2004 Sep; 13(17):1827-37. PubMed ID: 15229187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. De novo 13q31.1-q32.1 interstitial deletion encompassing the miR-17-92 cluster in a patient with Feingold syndrome-2.
    Tassano E; Di Rocco M; Signa S; Gimelli G
    Am J Med Genet A; 2013 Apr; 161A(4):894-6. PubMed ID: 23495052
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.